Ascension Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Hold
800
0.08% 71
2026
Q1
$281K Hold
800
0.09% 58
2025
Q4
$262K Hold
800
0.09% 40
2025
Q3
$226K Hold
800
0.09% 38
2025
Q2
$223K Hold
800
0.09% 35
2025
Q1
$249K Hold
800
0.11% 35
2024
Q4
$209K Hold
800
0.09% 34
2024
Q3
$258K Hold
800
0.12% 34
2024
Q2
$250K Hold
800
0.13% 30
2024
Q1
$227K Hold
800
0.13% 30
2023
Q4
$230K Sell
800
-872
-52% -$238K 0.15% 27
2023
Q3
$449K Buy
1,672
+68
+4% +$17K 0.26% 29
2023
Q2
$356K Hold
1,604
0.23% 29
2023
Q1
$388K Hold
1,604
0.3% 27
2022
Q4
$421K Hold
1,604
0.41% 26
2022
Q3
$362K Buy
1,604
+4
+0.3% +$970 0.39% 20
2022
Q2
$389K Hold
1,600
0.38% 21
2022
Q1
$387K Hold
1,600
0.31% 23
2021
Q4
$360K Hold
1,600
0.24% 28
2021
Q3
$340K Hold
1,600
0.22% 27
2021
Q2
$390K Buy
+1,600
New +$394K 0.25% 23

Other funds holding AMGN

Ascension Capital Advisors's AMGN Position: Q2 2026 in Review

Ascension Capital Advisors held its Amgen (AMGN) position steady in Q2 2026 at 800 shares worth $290K. The position accounts for 0.08% of the portfolio, ranked #71.

Ascension Capital Advisors first reported a position in AMGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $449K in Q3 2023. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ascension Capital Advisors held 800 shares of Amgen worth $290K as of Q2 2026.
  • Ascension Capital Advisors left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.08% of Ascension Capital Advisors's portfolio in Q2 2026, its #71 holding.
  • Ascension Capital Advisors first reported a position in Amgen in Q2 2021 and has held it in 21 quarters since.
  • Ascension Capital Advisors's Amgen position peaked at $449K in Q3 2023.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ascension Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.